Find a Doctor

Physician Photo

JA Jeevendra (Jeeva) Martyn, MD

Anaesthetist-in-Chief, Shriners Hospital for Children

Director, Clinical and Biochemical Pharmacology Laboratory

Anaesthetist, Masschusetts General Hospital

  • Phone: 617-726-8807
Departments
Department of Anesthesia, Critical Care and Pain Medicine

Specialties

  • MassGeneral Hospital for Children
  • Anesthesia
Clinical Interests
Pediatric anesthesia
Critical care
Physiology
Pharmacology
Burn injury
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, University of Ceylon - Sri Lanka
Residency, New York Presbyterian Hospital
Fellowship, Radcliffe Infirmary
Board Certifications
Anesthesiology, American Board of Anesthesiology
Critical Care Medicine, American Board of Anesthesiology
Gender
Male
Foreign Languages
Sinhala
Tamil
Patient Age Group
Adult and pediatric
Accepting New Patients
Yes

BiographyCritical illness with and without sepsis is associated with loss of skeletal muscle mass and muscle weakness. The skeletal muscle weakness results in hypoventilation, difficulties in weaning off respirators, contractures and decreased mobilization. Despite increased survival rates following burns and critical illness, the survivors have prolonged rehabilitation extending from months to years.

One recognized pathway for accelerated muscle protein breakdown is the ubiquitin-proteosome pathway. Our group has identified apoptosis as an additional mechanism for loss of muscle mass. In contrast to necrosis, this form of cell death is a gene-mediated, energy-dependent event. Our studies have demonstrated apoptosis in muscles following critical illness and/or immobilization alone, with upregulation of certain death-inducing molecules and downregulation of some anti-apoptotic genes and/or their proteins. Currently, our group is further characterizing the pro-apoptotic signaling pathways and finding methods to attenuate the apoptosis in these tissues. Inhibition of apoptosis may decrease critical illness-induced skeletal muscle wasting and weakness.

Critically ill patients also have insulin resistance, which leads to hyperglycemia, decreased glucose uptake in muscle, enhanced gluconeogenesis and glycogenolysis and decreased protein anabolism. Our group recently has characterized the molecular mechanism inducing this state in critical illness. The post receptor pathways that cause the insulin resistance include decreased phosphorylation of insulin receptor, insulin receptor substrate-1 and activation of Akt/PKB.

Similar biochemical changes in insulin signaling can be seen in immobilization and denervation states concomitantly associated with critical illness. Therefore, the anabolic actions of insulin, including glucose uptake and protein synthesis are impaired in critical illness of burns. Studies are ongoing on methods to enhance insulin signaling.

ResearchCritical illness with and without sepsis is associated with loss of skeletal muscle mass and muscle weakness. The skeletal muscle weakness results in hypoventilation, difficulties in weaning off respirators, contractures and decreased mobilization. Despite increased survival rates following burns and critical illness, the survivors have prolonged rehabilitation extending from months to years.

One recognized pathway for accelerated muscle protein breakdown is the ubiquitin-proteosome pathway. Our group has identified apoptosis as an additional mechanism for loss of muscle mass. In contrast to necrosis, this form of cell death is a gene-mediated, energy-dependent event. Our studies have demonstrated apoptosis in muscles following critical illness and/or immobilization alone, with upregulation of certain death-inducing molecules and downregulation of some anti-apoptotic genes and/or their proteins. Currently, our group is further characterizing the pro-apoptotic signaling pathways and finding methods to attenuate the apoptosis in these tissues. Inhibition of apoptosis may decrease critical illness-induced skeletal muscle wasting and weakness.

Critically ill patients also have insulin resistance, which leads to hyperglycemia, decreased glucose uptake in muscle, enhanced gluconeogenesis and glycogenolysis and decreased protein anabolism. Our group recently has characterized the molecular mechanism inducing this state in critical illness. The post receptor pathways that cause the insulin resistance include decreased phosphorylation of insulin receptor, insulin receptor substrate-1 and activation of Akt/PKB.

Similar biochemical changes in insulin signaling can be seen in immobilization and denervation states concomitantly associated with critical illness. Therefore, the anabolic actions of insulin, including glucose uptake and protein synthesis are impaired in critical illness of burns. Studies are ongoing on methods to enhance insulin signaling.

PublicationsView publications

In General: J.A. Jeevendra (Jeeva) Martyn, MD, and Jeannie T. Lee, MD, PhD

MGH Hotline 01.14.11 In General awards and honors

Shriner's Hospital for Children
51 Blossom Street
Boston, MA 02114

Phone: 617-726-8807
Fax: 617-371-4821

Anesthesia, Critical Care and Pain Medicine
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-3030

Shriner's Hospital for Children
51 Blossom Street
Boston, MA 02114

Phone: 617-726-8807
Fax: 617-371-4821

Anesthesia, Critical Care and Pain Medicine
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-3030

patient

Explore our community locations

You can see MassGeneral for Children specialists in more than a dozen locations throughout Eastern Massachusetts and Southern New Hampshire.

patient

Make an appointment

Contact MassGeneral Hospital for Children to schedule an appointment with one of our specialists.

patient

Refer a patient

Referring a patient to MassGeneral Hospital for Children is easy.